SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be prominently featured at the 2026 Society of Robotic Surgery Annual Meeting, taking place July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, highlighted in multiple breakout sessions, and used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in multiple sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries, while approximately 2,100 physicians have been trained on the platform.
The announcement underscores SS Innovations' mission to make robotic surgery affordable and accessible globally. The company’s product range includes the SSi Mantra system and its comprehensive suite of SSi Mudra surgical instruments, supporting a variety of procedures including cardiac surgery. For more details, the full press release can be viewed at https://ibn.fm/YYYKE.
This event is significant as it highlights the rapid adoption and capabilities of the SSi Mantra system, particularly in telesurgery, which could expand access to specialized surgical care in underserved regions. The live broadcast of a remote partial nephrectomy demonstrates the system's reliability and potential for remote procedures. With over 12,000 procedures performed and a growing number of trained physicians, the SSi Mantra is positioning itself as a key player in the global robotic surgery market.
Dr. Srivastava’s participation in sessions on regulatory frameworks and global access indicates the company’s focus on navigating international standards to expand its reach. The inclusion of pediatric and cardiac procedures in the system’s portfolio suggests its versatility across surgical specialties.
The Society of Robotic Surgery Annual Meeting provides a platform for industry leaders to discuss advancements and challenges. SS Innovations’ presence there signals its commitment to shaping the future of robotic surgery. For investors, the company’s progress in telesurgery and training metrics offers insight into its growth trajectory.
As with any forward-looking statements, the company cautions that actual results may differ materially due to risks and uncertainties, as detailed in its SEC filings. The full terms of use and disclaimers are available at http://IBN.fm/Disclaimer.
